Fulminant Clostridium difficile Enteritis after Proctocolectomy and Ileal Pouch-Anal Anastamosis by Boland, Elena & Thompson, Jon S.
Hindawi Publishing Corporation
Gastroenterology Research and Practice
Volume 2008, Article ID 985658, 5 pages
doi:10.1155/2008/985658
CaseReport
Fulminant Clostridium difﬁcile Enteritis after Proctocolectomy
and Ileal Pouch-Anal Anastamosis
Elena Boland and Jon S. Thompson
Department of Surgery, University of Nebraska Medical Center, 983280 Nebraska Medical Center Omaha, NE 68198-3280, USA
Correspondence should be addressed to Elena Boland, eboland@unmc.edu
Received 26 October 2008; Accepted 6 December 2008
Recommended by Paolo Gionchetti
Clostridium diﬃcile (C. diﬃcile) infection of the small bowel is very rare. The disease course is more severe than that of C. diﬃcile
colitis, and the mortality is high. We present a case of C. diﬃcile enteritis in a patient with ileal pouch-anal anastamosis (IPAA),
and review previous case reports in order to better characterize this unusual condition.
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1. INTRODUCTION
C. diﬃcile infection is associated with antibiotic-induced
pseudomembranous colitis. This infection is usually thought
to be restricted to the colon. Isolated small bowel C.
diﬃcile enteritis is rare and can manifest in the absence of
ac o l o n .
C. diﬃcile has been shown to colonize small bowel
mucosa in about 3% of the population, which then serves as
a reservoir for infection [1]. Most carriers are asymptomatic.
Altered intestinal anatomy and antibiotic use have been
implicatedintriggeringsymptomaticinfection.Fecalﬂorain
the small bowel of patients who had undergone a colectomy
is altered to resemble that of the colon. Morphological
changes (colonic-type metaplasia with partial villous atro-
phy) which occur in the mucosa of an ileal pouch secondary
to altered fecal ﬂow may predispose to infection [2]. These
factors may increase small bowel colonization by C. diﬃcile.
Alterationoffecalﬂorabyantibioticcantriggersymptomatic
infection.
The clinical presentation of C. diﬃcile colitis is typically
mild, occasionally progressing to fulminant colitis. The
disease course is more fulminant when small bowel is
aﬀected, with reported mortality ranging from 60–83% [3].
We report a case of fulminant C. diﬃcile enteritis in a
patientwithilealpouch-analanastamosis(IPAA),andreview
previous reports of this unusual condition.
2. REPORT OF A CASE
A 42-year-old man underwent proctocolectomy with IPAA
and ileostomy for medically refractory ulcerative colitis
(UC). The patient returned for ileostomy takedown six
months later. His hospital course was complicated by a
urinary tract infection, which was treated with ciproﬂoxacin.
The patient was discharged tolerating a regular diet with
good bowel function. The patient returned 10 days later
complaining of a three-day history of nausea, diarrhea,
and abdominal pain. Patient was febrile (38.3◦C), tachy-
cardic (138), with elevated white blood cell count (17.000),
creatinine (2.5), and platelet count (1450). CT scan of
the abdomen showed dilated small bowel with ﬂuid and
air to the ileoanal anastomosis. Blood, urine, and stool
cultures were sent, and empiric intravenous piperacillin/
tazobactam and vancomycin were started. However, the
patient became progressively more septic and required
vasopressors for blood pressure support. Unexpectedly, C.
diﬃcile enzyme immunoassay (EIA) came back positive for
toxins A and B, and the patient started on oral vancomycin
and metronidazole. Flexible endoscopy was performed and
revealed copious amounts of mucus with adherent pseu-
domembranes throughout the pouch and distal small bowel
(Figure 1). Over the next few days, the patient remained in
critical condition, but then slowly stabilized. Vasopressors
were weaned; WBC and creatinine came down to normal2 Gastroenterology Research and Practice
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Figure 1: Flexible endoscopy of pelvic pouch demonstrating copious amounts of mucus with adherent pseudomembranes throughout the
pouch and distal small bowel, consistent with C. diﬃcile infection.
limits. Within 7 days of admission, patient was restarted
on a diet and was ultimately discharged after a 12-day
hospitalization. At one year follow up, the patient still
occasionally has frequent bowel movements, but his stool
cultures have remained negative for C. diﬃcile toxins.
3. DISCUSSION
PubMed literature search for C. diﬃcile enteritis was per-
formed and revealed 26 cases from 1980–2008 (Table 1)[ 3–
22]. There was signiﬁcant age variability, with a range of 18
to 83 years of age (mean 50.3). Sixteen of the 26 patients
had inﬂammatory bowel disease (IBD), thirteen patients had
ulcerative colitis, and three had Crohn’s disease. Ten patients
had total colectomies and six underwent IPAA. All but three
patients had altered intestinal anatomy. Twenty four patients
had recent hospitalization and/or operation as well as recent
antibiotic use. Thirteen patients were septic and required
ICU admission. In all 26 cases, the stool assays were positive
for C. diﬃcile toxin. Diagnosis of small bowel involvement
was made based on biopsy, pathology, or autopsy results.
Only seven patients were evaluated endoscopically. Four
underwent ﬂexible sigmoidoscopy, and three of those had
pseudomembranes. Of the patients with IPAA, only two
were examined endoscopically and no pseudomembranes
were visualized. One patient had an esophagogastroduo-
denoscopy (EGD) which demonstrated pseudomembranes
in the duodenum. Treatment in all but two patients included
metronidazole or vancomycin, or a combination of both.
Two patients were resistant to metronidazole. Fourteen of
the 26 underwent operative intervention. Mortality rate was
35%.
Our patient was similar to the previously reported cases
of C. diﬃcile enteritis in that he had a history of IBD, recent
surgery, and antibiotic use. He required ICU admission
secondary to sepsis, but he did not require operative
intervention. Unlike any of the previously reported cases,
our patient’s pouch endoscopy revealed pseudomembranes,
facilitating timely intervention and his ultimate recovery.
C. diﬃcile enteritis appears to have a fulminant course,
with high risk of sepsis, need for operation, and mortality.
It is unclear why the disease course is more severe than in
colitis. Increased small bowel permeability is one potential
explanation. Delay in diagnosis and treatment may play a
role as well.
The clinical presentation can be similar for both enteritis
and colitis. Symptoms include diarrhea, dehydration, and
increased ileostomy output. Unlike colitis, enteritis more
commonly presents with systemic manifestations such as
fever,hypotension,leukocytosisandthrombocytosis[3],and
occasionally with peritonitis or bowel perforation [7, 17].
C. diﬃcile enteritis may be diﬃcult to diﬀerentiate from
other inﬂammatory processes, and requires high degree of
suspicion to make the diagnosis. C. diﬃcile has also been
implicated as a cause of chronic pouchitis in patients with
IPAA [16], and should be suspected in this setting. GivenE. Boland and J. S. Thompson 3
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the higher risk that IBD patients may have for developing
C. diﬃcile enteritis, it is important to be able to diﬀerentiate
it from an exacerbation of IBD. Diagnosis is made by
identifying C. diﬃcile toxin A or B in the stool. Similarly,
endoscopyshouldbeutilizedinpatientswithsuspectedsmall
bowel involvement even with history of prior colectomy.
This may facilitate diﬀerentiation between Crohn’s enteritis,
pouchitis, and C. diﬃcile enteritis.
As with our patient, most cases will respond to treatment
with metronidazole or vancomycin. However, more virulent
and resistant strains have been reported [23]. Some patients
will need emergent surgical resection of any perforated
or gangrenous bowel if they fail to respond to medical
treatment.
C. diﬃcile enteritis is emerging with increased frequency
and can have devastating results. Patients with IBD and prior
colectomy are at increased risk. Prompt identiﬁcation of the
organismviastool cultureandendoscopy mayresultinmore
favorable outcomes.
NOMENCLATURE
APR: Abdominoperineal resection
TAC: Total abdominal colectomy
TPC: Total proctocolectomy
IPAA: Ileal pouch-anal anastamosis.
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